These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31350552)

  • 1. Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Hu J; Fan S; Yuan P; Karmouch J; Czernuszewicz G; Robertson MJ; Coarfa C; Hong K; Yao Y; Campbell H; Wehrens X; Gurha P; Marian AJ
    Cardiovasc Res; 2020 May; 116(6):1199-1213. PubMed ID: 31350552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic inactivation of β-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Olcum M; Fan S; Rouhi L; Cheedipudi S; Cathcart B; Jeong HH; Zhao Z; Gurha P; Marian AJ
    Cardiovasc Res; 2023 Dec; 119(17):2712-2728. PubMed ID: 37625794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy.
    Yuan P; Cheedipudi SM; Rouhi L; Fan S; Simon L; Zhao Z; Hong K; Gurha P; Marian AJ
    Circulation; 2021 Jun; 143(22):2169-2187. PubMed ID: 33726497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
    Rouhi L; Cheedipudi SM; Chen SN; Fan S; Lombardi R; Chen X; Coarfa C; Robertson MJ; Gurha P; Marian AJ
    Cardiovasc Res; 2021 Sep; 117(11):2377-2394. PubMed ID: 33070193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Fan S; Rouhi L; Marian AJ
    J Cardiovasc Aging; 2021; 1(3):. PubMed ID: 34447973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Rouhi L; Fan S; Cheedipudi SM; Braza-Boïls A; Molina MS; Yao Y; Robertson MJ; Coarfa C; Gimeno JR; Molina P; Gurha P; Zorio E; Marian AJ
    Cardiovasc Res; 2022 May; 118(6):1466-1478. PubMed ID: 34132777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model.
    Lyon RC; Mezzano V; Wright AT; Pfeiffer E; Chuang J; Banares K; Castaneda A; Ouyang K; Cui L; Contu R; Gu Y; Evans SM; Omens JH; Peterson KL; McCulloch AD; Sheikh F
    Hum Mol Genet; 2014 Mar; 23(5):1134-50. PubMed ID: 24108106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PANoptosis is a prominent feature of desmoplakin cardiomyopathy.
    Olcum M; Rouhi L; Fan S; Gonzales MM; Jeong HH; Zhao Z; Gurha P; Marian AJ
    J Cardiovasc Aging; 2023 Feb; 3(1):. PubMed ID: 36818425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling.
    Martherus R; Jain R; Takagi K; Mendsaikhan U; Turdi S; Osinska H; James JF; Kramer K; Purevjav E; Towbin JA
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H174-87. PubMed ID: 26545710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.
    Karmouch J; Zhou QQ; Miyake CY; Lombardi R; Kretzschmar K; Bannier-Hélaouët M; Clevers H; Wehrens XHT; Willerson JT; Marian AJ
    Circ Res; 2017 Dec; 121(12):1346-1359. PubMed ID: 29018034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing identified novel Desmoplakin frame-shift variant in patients with Arrhythmogenic cardiomyopathy.
    Lin X; Ma Y; Cai Z; Wang Q; Wang L; Huo Z; Hu D; Wang J; Xiang M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):74. PubMed ID: 32046637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.
    Lombardi R; Chen SN; Ruggiero A; Gurha P; Czernuszewicz GZ; Willerson JT; Marian AJ
    Circ Res; 2016 Jun; 119(1):41-54. PubMed ID: 27121621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Yang Z; Bowles NE; Scherer SE; Taylor MD; Kearney DL; Ge S; Nadvoretskiy VV; DeFreitas G; Carabello B; Brandon LI; Godsel LM; Green KJ; Saffitz JE; Li H; Danieli GA; Calkins H; Marcus F; Towbin JA
    Circ Res; 2006 Sep; 99(6):646-55. PubMed ID: 16917092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    Chelko SP; Asimaki A; Lowenthal J; Bueno-Beti C; Bedja D; Scalco A; Amat-Alarcon N; Andersen P; Judge DP; Tung L; Saffitz JE
    Circulation; 2019 Oct; 140(18):1491-1505. PubMed ID: 31533459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiac myocyte CXCR4 expression in development and left ventricular remodeling after acute myocardial infarction.
    Agarwal U; Ghalayini W; Dong F; Weber K; Zou YR; Rabbany SY; Rafii S; Penn MS
    Circ Res; 2010 Sep; 107(5):667-76. PubMed ID: 20634485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
    Bermúdez-Jiménez FJ; Carriel V; Brodehl A; Alaminos M; Campos A; Schirmer I; Milting H; Abril BÁ; Álvarez M; López-Fernández S; García-Giustiniani D; Monserrat L; Tercedor L; Jiménez-Jáimez J
    Circulation; 2018 Apr; 137(15):1595-1610. PubMed ID: 29212896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte Hypertrophy in Arrhythmogenic Cardiomyopathy.
    Gerçek M; Gerçek M; Kant S; Simsekyilmaz S; Kassner A; Milting H; Liehn EA; Leube RE; Krusche CA
    Am J Pathol; 2017 Apr; 187(4):752-766. PubMed ID: 28183531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
    Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
    Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized
    Stevens TL; Manring HR; Wallace MJ; Argall A; Dew T; Papaioannou P; Antwi-Boasiako S; Xu X; Campbell SG; Akar FG; Borzok MA; Hund TJ; Mohler PJ; Koenig SN; El Refaey M
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.
    Boogerd CJ; Lacraz GPA; Vértesy Á; van Kampen SJ; Perini I; de Ruiter H; Versteeg D; Brodehl A; van der Kraak P; Giacca M; de Jonge N; Junker JP; van Oudenaarden A; Vink A; van Rooij E
    Cardiovasc Res; 2023 Mar; 119(2):477-491. PubMed ID: 35576477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.